Literature DB >> 8015979

C-type natriuretic peptide in the human central nervous system: distribution and molecular form.

K Totsune1, K Takahashi, M Ohneda, K Itoi, O Murakami, T Mouri.   

Abstract

The distribution and molecular form of C-type natriuretic peptide (CNP) in the human central nervous system were studied with a specific radioimmunoassay for CNP-22. Immunoreactive (IR-) CNP was detectable in all regions of the brain examined (cerebral cortex, thalamus, hypothalamus, pons, and cerebellum) (0.21-0.81 pmol/g wet tissue, n = 4). The highest concentration of IR-CNP was found in the spinal cord at 1.83 +/- 0.13 pmol/g wet tissue (mean +/- SD, n = 3). Reversed-phase high performance liquid chromatography revealed a major peak migrating at the position corresponding to synthetic human CNP-53 and minor peaks comigrating with synthetic CNP-22 and the methionine-oxidized form of CNP-22, respectively. These findings suggest that IR-CNP is widely present in the human central nervous system mainly in a high molecular weight form as the major component and in the molecular form of CNP-22 as the minor component.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015979     DOI: 10.1016/0196-9781(94)90167-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Role of anterior hypothalamic natriuretic peptide in lipopolysaccharide-induced fever in rats.

Authors:  Michio Miyoshi; Tatsuo Watanabe
Journal:  Eur J Appl Physiol       Date:  2009-08-23       Impact factor: 3.078

3.  Urinary C-type natriuretic peptide: a new heart failure biomarker.

Authors:  Rosita Zakeri; S Jeson Sangaralingham; Sharon M Sandberg; Denise M Heublein; Christopher G Scott; John C Burnett
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

4.  Localization of Brain Natriuretic Peptide Immunoreactivity in Rat Spinal Cord.

Authors:  Essam M Abdelalim; Jean-Pierre Bellier; Ikuo Tooyama
Journal:  Front Neuroanat       Date:  2016-12-02       Impact factor: 3.856

5.  Environmental Enrichment Elicits a Transient Rise of Bioactive C-Type Natriuretic Peptide in Young but Not Aged Rats.

Authors:  Susan A Rapley; Timothy C R Prickett; John C Dalrymple-Alford; Eric A Espiner
Journal:  Front Behav Neurosci       Date:  2018-07-19       Impact factor: 3.558

Review 6.  Current and emerging drug targets in heart failure treatment.

Authors:  Nicolò Ghionzoli; Francesco Gentile; Anna Maria Del Franco; Vincenzo Castiglione; Alberto Aimo; Alberto Giannoni; Silvia Burchielli; Matteo Cameli; Michele Emdin; Giuseppe Vergaro
Journal:  Heart Fail Rev       Date:  2021-07-17       Impact factor: 4.654

7.  C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

Authors:  Cristina Perez-Ternero; Patrick N Pallier; Jordi L Tremoleda; Alessio Delogu; Cathy Fernandes; Adina T Michael-Titus; Adrian J Hobbs
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

Review 8.  The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Authors:  Massimo Volpe; Marino Carnovali; Vittoria Mastromarino
Journal:  Clin Sci (Lond)       Date:  2016-01       Impact factor: 6.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.